// June 26, 2023
Complex generics: Are global regulators addressing the needs?
The development of generic versions of innovator medicines is a global public health need.
The development of generic versions of innovator medicines is a global public health need.
Interest in innovative vaccines that use messenger ribonucleic acid (mRNA) and viral vectored tec
With significant innovations in pharmaceuticals, including biologic drugs
The quality of medicine and how it’s delivered to patients is fundamental to treating illness and